๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Block Copolymers: Past Successes and Future Challenges

โœ Scribed by Timothy P. Lodge


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
114 KB
Volume
204
Category
Article
ISSN
1022-1352

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Block copolymers are the focus of a great deal of research activity in contemporary macromolecular science. This is attributable to a range of fascinating fundamental issues associated with understanding selfโ€assembly processes in both solution and in bulk, coupled to an adventitious convergence of substantial progress in synthetic versatility, developments in molecular and structural characterization, understanding of the factors that control phase behavior, and elucidation of the response of copolymer materials to external fields. It is argued that due to the rapid progress in these areas block copolymers now stand on the verge of a new generation of sophisticated materials applications, in which particular nanostructures will play a crucial role. This may be contrasted with the current billion dollar annual market for block copolymer materials, in which no substantial advantage is taken of any particular nanostructure. A variety of persistent challenges are identified that stand between block copolymers and widespread success in novel applications; foremost amongst these are issues concerned with processing.


๐Ÿ“œ SIMILAR VOLUMES


NON-GOVERNMENTAL ORGANIZATIONS IN INTERN
โœ GEORGE A. GELLERT ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 824 KB

Non-governmental organizations, or NGOs, are increasingly instrumental to the implementation of international health programs. Following an overview of current conditions in global health and the problems that could be targeted by N O S , this article describes the activities and philosophies of sev

Pediatric cancer survivors: past history
โœ Anna T. Meadows ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 90 KB

odern therapy for childhood cancer began about 1970, and by the middle of that decade many children who had discontinued treatment continued to remain in remission. Clinical trials have confirmed that there are large numbers of youngsters and young adults who are cured and who have many years of pro